These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27464717)

  • 1. Plant-Derived Biomolecules and Drug Delivery Systems in the Treatment of Liver and Kidney Diseases.
    Hermenean A; Smeu C; Gharbia S; Krizbai IA; Ardelean A
    Curr Pharm Des; 2016; 22(35):5415-5441. PubMed ID: 27464717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in natural products from plants for treatment of liver diseases.
    Zhang A; Sun H; Wang X
    Eur J Med Chem; 2013 May; 63():570-7. PubMed ID: 23567947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of marine-derived bioactive compounds as potential hepatoprotective agents.
    Nair DG; Weiskirchen R; Al-Musharafi SK
    Acta Pharmacol Sin; 2015 Feb; 36(2):158-70. PubMed ID: 25500871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targeting to the diseased liver.
    Poelstra K; Prakash J; Beljaars L
    J Control Release; 2012 Jul; 161(2):188-97. PubMed ID: 22370583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney-targeted therapies: A quantitative perspective.
    van Asbeck AH; Dieker J; Boswinkel M; van der Vlag J; Brock R
    J Control Release; 2020 Dec; 328():762-775. PubMed ID: 32931896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kidney as a target organ in pharmaceutical research.
    Prunotto M; Gabbiani G; Pomposiello S; Ghiggeri G; Moll S
    Drug Discov Today; 2011 Mar; 16(5-6):244-59. PubMed ID: 21129499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.
    Liu CP; Hu Y; Lin JC; Fu HL; Lim LY; Yuan ZX
    Med Res Rev; 2019 Mar; 39(2):561-578. PubMed ID: 30136283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.
    Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
    Curr Med Chem; 2012; 19(14):2176-228. PubMed ID: 22414104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells.
    Dolman ME; Harmsen S; Storm G; Hennink WE; Kok RJ
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1344-57. PubMed ID: 20719242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-food-derived bioactives: Key health benefits and current nanosystems as a strategy to enhance their bioavailability.
    Salehi B; Rodrigues CF; Can Karaca A; Gülseren G; Şenol E; Demircan E; Özçelik B; Tutuncu S; Sharopov F; Sharifi-Rad J; Maroyi A; Martins N
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(4):232-242. PubMed ID: 32583797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Products as Anticancerous Therapeutic Molecules with Special Reference to Enzymatic Targets Topoisomerase, COX, LOX and Aromatase.
    Singh S; Awasthi M; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2018; 19(3):238-274. PubMed ID: 28059043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural product-based nanomedicine: recent advances and issues.
    Watkins R; Wu L; Zhang C; Davis RM; Xu B
    Int J Nanomedicine; 2015; 10():6055-74. PubMed ID: 26451111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New biologics for glomerular disease on the horizon.
    Karras A; Jayne D
    Nephron Clin Pract; 2014; 128(3-4):283-91. PubMed ID: 25402272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The liver-cell specific drug delivery system].
    Goto M
    Nihon Rinsho; 1994 Aug; 52(8):2214-24. PubMed ID: 7933613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-Derived Natural Products for Parkinson's Disease Therapy.
    Sengupta T; Vinayagam J; Singh R; Jaisankar P; Mohanakumar KP
    Adv Neurobiol; 2016; 12():415-96. PubMed ID: 27651267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cell-targeted delivery of therapeutic molecules.
    Kang JH; Toita R; Murata M
    Crit Rev Biotechnol; 2016; 36(1):132-43. PubMed ID: 25025274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance.
    Rohilla R; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016 Jun; 23(5):1645-61. PubMed ID: 25101832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant-Derived Peptides: (Neglected) Natural Products for Drug Discovery.
    Gruber CW
    Planta Med; 2024 Jun; 90(7-08):627-630. PubMed ID: 38843800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.